1. Home
  2. PSTV vs ATIF Comparison

PSTV vs ATIF Comparison

Compare PSTV & ATIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • ATIF
  • Stock Information
  • Founded
  • PSTV 1996
  • ATIF 2015
  • Country
  • PSTV United States
  • ATIF China
  • Employees
  • PSTV N/A
  • ATIF N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • ATIF Professional Services
  • Sector
  • PSTV Health Care
  • ATIF Consumer Discretionary
  • Exchange
  • PSTV Nasdaq
  • ATIF Nasdaq
  • Market Cap
  • PSTV 9.9M
  • ATIF 11.2M
  • IPO Year
  • PSTV N/A
  • ATIF 2019
  • Fundamental
  • Price
  • PSTV $1.75
  • ATIF $0.86
  • Analyst Decision
  • PSTV Strong Buy
  • ATIF
  • Analyst Count
  • PSTV 1
  • ATIF 0
  • Target Price
  • PSTV $8.00
  • ATIF N/A
  • AVG Volume (30 Days)
  • PSTV 55.5K
  • ATIF 4.7K
  • Earning Date
  • PSTV 08-12-2024
  • ATIF 06-14-2024
  • Dividend Yield
  • PSTV N/A
  • ATIF N/A
  • EPS Growth
  • PSTV N/A
  • ATIF N/A
  • EPS
  • PSTV N/A
  • ATIF N/A
  • Revenue
  • PSTV $6,084,000.00
  • ATIF $500,000.00
  • Revenue This Year
  • PSTV $5.21
  • ATIF N/A
  • Revenue Next Year
  • PSTV N/A
  • ATIF N/A
  • P/E Ratio
  • PSTV N/A
  • ATIF N/A
  • Revenue Growth
  • PSTV 733.42
  • ATIF N/A
  • 52 Week Low
  • PSTV $0.97
  • ATIF $0.65
  • 52 Week High
  • PSTV $3.21
  • ATIF $2.00
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 47.92
  • ATIF 58.53
  • Support Level
  • PSTV $1.70
  • ATIF $0.85
  • Resistance Level
  • PSTV $1.92
  • ATIF $0.96
  • Average True Range (ATR)
  • PSTV 0.17
  • ATIF 0.07
  • MACD
  • PSTV 0.03
  • ATIF 0.01
  • Stochastic Oscillator
  • PSTV 52.24
  • ATIF 70.53

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About ATIF ATIF Holdings Limited

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

Share on Social Networks: